Lumito holds presentation on the Nordic Symposium on Digital Pathology
On 16 May, Lumito will demonstrate its technology under the theme "Open Innovation" on the Nordic Symposium on Digital Pathology in Linköping, with 200 expected participants from more than 10 countries.
- This is an excellent opportunity to give a comprehensive presentation of our technology, and to meet pathologists and other representatives in the field of digital pathology, says Stefan Nilsson, CEO of Lumito.
For more information contact:
Lumito AB (publ), CEO Stefan Nilsson, telefon +46 767 78 59 05, firstname.lastname@example.org
Lumito in brief
Lumito is specialised in research and development of imaging technologies for medical applications. The technology is based on so called UCNP:s (Up Converting Nano Particles) and is aiming to increase image quality in biomedical applications. Lumito´s IPR covers imaging with high quality of for instance tissue samples, with UCNP:s as markers. The technology has several possible application areas, but Lumito has initially decided to focus on digital pathology. Lumito has an agreement with TTP plc (The Technology Partnership) in Cambridge, UK, regarding development of instruments and staining reagents. Lumito’s share Lumito and warrant Lumito TO1 are traded at the NGM Nordic MTF marketplace.